Outcomes of Gillian Barrie Syn
NCT07208370 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2025-10-06
Summary
This study analyze clinical and biological factors influencing disease course and outcome. Some research identified factors like disease severity, sensory symptoms, and autonomic instability as indicators of poor outcome. Ongoing research aims to develop accurate predictive models for improved treatment and care.
Conditions
- Outcome of Gillian Barrie
Interventions
- OTHER
-
clinical assessment
standraized clinical evaluation to assess disease sevirity and progration
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-01
- Primary Completion
- 2026-10-01
- Completion
- 2026-12-01
Countries
- Egypt
Study Locations
More Related Trials
-
Natural History Studies of Mucopolysaccharidosis III
NCT02037880 ·Status: COMPLETED
-
Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia
NCT06560346 ·Status: WITHDRAWN
-
Prenatal Screening For Smith-Lemli-Opitz Syndrome
NCT00070850 ·Status: COMPLETED
-
The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)
NCT05705674 ·Status: RECRUITING
-
Biomarkers Related to Bone in Pediatric Gaucher Disease
NCT06116071 ·Status: RECRUITING
-
A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy
NCT03570931 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB
NCT02293382 ·Status: COMPLETED
-
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)
NCT06617429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of the Effects of Fabrazyme Treatment on Lactation and Infants
NCT00230607 ·Status: TERMINATED ·Phase: PHASE4
-
Mucopolysaccharidosis Type II Natural History
NCT03529786 ·Status: COMPLETED
-
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
NCT07157254 ·Status: RECRUITING ·Phase: PHASE2
-
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
NCT01707433 ·Status: COMPLETED
-
A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome
NCT04007536 ·Status: COMPLETED
-
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
NCT02293408 ·Status: TERMINATED
-
A Study of GLWL-01 in Patients With Prader-Willi Syndrome
NCT03274856 ·Status: COMPLETED ·Phase: PHASE2
-
The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
NCT01123863 ·Status: COMPLETED
-
Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation
NCT06706388 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
NCT03047980 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Natural History of Netherton Syndrome
NCT05902663 ·Status: TERMINATED
-
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
NCT02790034 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications
NCT02012114 ·Status: COMPLETED ·Phase: NA
-
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
NCT01675674 ·Status: TERMINATED
-
A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.
NCT07266324 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Natural History of Infantile Globoid Cell Leukodystrophy
NCT00983879 ·Status: COMPLETED
-
A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
NCT04259281 ·Status: COMPLETED ·Phase: PHASE1/PHASE2